A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastatic) Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Stage IV (Metastatic) Breast Cancer
Interventions: DRUG: ABI-007|DRUG: vinorelbine|DRUG: Trastuzumab|BIOLOGICAL: G-CSF
Sponsor: Celgene